Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-07-19

Clinical Trial Update: EarlySense Monitoring Device Evaluation on CHF Patients

View source ↗

Summary

A clinical trial evaluating the EarlySense monitoring device in patients with congestive heart failure has been withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: EarlySense Ltd. | Conditions: Congestive Heart Failure | Status: WITHDRAWN